| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/24/2002 | US20020156055 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 10/24/2002 | US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 10/24/2002 | US20020156053 Treating gastro-oesophageal reflux disease |
| 10/24/2002 | US20020156052 Tricyclic opiod receptor agonists |
| 10/24/2002 | US20020156051 Atherosclerosis and hyperlipidemia; ascorbic acid and anticholesterol agents that are 3-hydroxy-3-methyl glutaryl coenzyme-A reductase inhibitors |
| 10/24/2002 | US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors |
| 10/24/2002 | US20020156047 Multi-arm block copolymers as drug delivery vehicles |
| 10/24/2002 | US20020156045 Magnesium chloride improves efficiency of transfection of polynucleotide; drug delivery; vaccination |
| 10/24/2002 | US20020156044 Use of EXT genes for the treatment of cancer and other diseases |
| 10/24/2002 | US20020156042 Human suppressor tRNA oligonucleotides and methods of use for same |
| 10/24/2002 | US20020156033 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| 10/24/2002 | US20020156030 Heterocyclic aromatic compounds and uses thereof |
| 10/24/2002 | US20020156029 A kit for treating transient acantholytic dermatitis, acne miliaris necrotica, acne varioliformis, perioral dermatitis, or acneiform eruptions comprising, e.g., ivermectin, and a carrier |
| 10/24/2002 | US20020156028 Macrolide antiinfective agents |
| 10/24/2002 | US20020156027 Ketolide antibiotics |
| 10/24/2002 | US20020156025 Inhibition of vacuolar proton ATPase activity and/or the modulation of acidic organelle function sensitizes cells to radiation, chemotherapy and biological agents |
| 10/24/2002 | US20020156024 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 10/24/2002 | US20020156023 Lometrexol combination therapy |
| 10/24/2002 | US20020156022 Compounds and methods for treating transplant rejection |
| 10/24/2002 | US20020156021 Antihistaminic/Antitussive compositions |
| 10/24/2002 | US20020156020 Fructosamine oxidase: antagonists and inhibitors |
| 10/24/2002 | US20020156016 Control of cell growth by altering cell membrane potentials |
| 10/24/2002 | US20020156013 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/24/2002 | US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/24/2002 | US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use |
| 10/24/2002 | US20020155997 Biologically active material isolated from non-pathogenic bacteria, such as Enterobacteriaceae |
| 10/24/2002 | US20020155992 Paclitaxel, epipodophyllotoxin, decetaxel, topotecan, and podophyllotoxin covalently conjugated to a polypeptide drug carrier having 50-90% by weight glutamic acid; inproved solubility |
| 10/24/2002 | US20020155991 Polyamino acid derivtive is applied to skin to improve the "camouflaging" and/or fading out of the wrinkles and/or fine lines already formed |
| 10/24/2002 | US20020155988 Uses of transport proteins |
| 10/24/2002 | US20020155986 Use of an AT1 or AT2 receptor antagonist for producing a pharmaceutical preparation for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors |
| 10/24/2002 | US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy |
| 10/24/2002 | US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies |
| 10/24/2002 | US20020155534 SBHWSB2: a new member of the WD40 SOCS box family |
| 10/24/2002 | US20020155528 Regulation of human CysLT2-like GPCR protein |
| 10/24/2002 | US20020155519 Human blood bacterium |
| 10/24/2002 | US20020155470 Intercalation compound for use in the diagnosis and detection of genetic disorders |
| 10/24/2002 | US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 10/24/2002 | US20020155432 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 10/24/2002 | US20020155426 Prevention and treatment of amyloid-associated disorders |
| 10/24/2002 | US20020155181 Method and composition for improving sexual fitness |
| 10/24/2002 | US20020155178 Compositions and methods for cancer prevention and treatment derived from Inula britannica |
| 10/24/2002 | US20020155175 Natural cell control carrier modular compounded inula helenium L. extract and water-soluble chitosan |
| 10/24/2002 | US20020155173 Central nervous system disorders; cognition activators |
| 10/24/2002 | US20020155172 Central nervous system disorders |
| 10/24/2002 | US20020155171 Mixtures of peptide, minerals and vitamins |
| 10/24/2002 | US20020155170 Detoxification of heavy metals; adjustment concentration of metallothionein |
| 10/24/2002 | US20020155168 Use of rare earth compounds for the prevention of kidney stone disease |
| 10/24/2002 | US20020155163 Integrated multi-vitamin and mineral combination |
| 10/24/2002 | US20020155156 For forming controlled release formulation of a therapeutic agent; for coating solid dosage |
| 10/24/2002 | US20020155153 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
| 10/24/2002 | US20020155151 For therapy of diseases of the cardiovascular system, lung, muscles, stomach and bowels (ulcer and gastritis), diabetes, skin, nerves, tinnitus, in degenerative metabolic imbalance, incontinence, periodontosis, mitochondrial diseases |
| 10/24/2002 | US20020155150 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients |
| 10/24/2002 | US20020155147 To eliminate Boophilus microplus in cattle and lice and blowfly in sheep |
| 10/24/2002 | US20020155144 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 10/24/2002 | US20020155141 Pharmacologically acceptable solvent vehicles |
| 10/24/2002 | US20020155136 Using in combination, of yohimbine and arginine as active ingredients in the preparation of a medicinal product intended for treating erectile dysfunction |
| 10/24/2002 | US20020155123 Compositions and methods for inhibiting HIV infection |
| 10/24/2002 | US20020155121 Virus coat protein/receptor chimeras and methods of use |
| 10/24/2002 | US20020155115 Cancer therapy |
| 10/24/2002 | US20020155107 Methods and formulations for reducing circulating antibodies |
| 10/24/2002 | US20020155104 Altering T cell mediated immunity comprising altering local extracellular concentrations of tryptophan and tryptophan metabolites |
| 10/24/2002 | US20020155103 Activated charcoal based composition and method for reducing hangover symptomps associated with the consumption of alcohol containing beverages |
| 10/24/2002 | US20020155102 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells |
| 10/24/2002 | US20020155101 Cardiac arrhythmia treatment methods |
| 10/24/2002 | US20020155100 Compositions and methods for regulated protein expression in gut |
| 10/24/2002 | US20020155097 For therapy and prophylaxis of cancer and tumors |
| 10/24/2002 | US20020155094 Method of treating sepsis and ARDS using chemokine beta-9 |
| 10/24/2002 | US20020155091 For reducing serum cholesterol in a mammal |
| 10/24/2002 | US20020155088 Administering to the tumor site an oligoaniline and subsequently exposing the tumor site to irradiation |
| 10/24/2002 | US20020155082 Siloxane dyes, compositions containing them and uses thereof |
| 10/24/2002 | US20020155074 May be used in the beautification, care and maintenance of health of skin, hair and nails |
| 10/24/2002 | US20020155068 Inhalatory compositions of formoterol |
| 10/24/2002 | US20020155067 For drug delivery |
| 10/24/2002 | US20020155066 For pulmonary administration of highly toxic or vesicating anticancer drugs |
| 10/24/2002 | EP1212298A4 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine |
| 10/24/2002 | DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway |
| 10/24/2002 | DE10119423A1 New cyanoimino- or nitroimino-substituted azole derivatives or analogs, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents |
| 10/24/2002 | DE10113604A1 Verfahren zur Spaltung des humanen Wachstumshormons GH A process for cleavage of human growth hormone GH |
| 10/24/2002 | DE10061136C1 Stable, rapidly disintegrating tablets containing proton pump inhibitors, useful for treating elevated gastric secretion, comprising multiple drug units and auxiliaries including basic filler |
| 10/24/2002 | CA2770489A1 Bisphosphonate conjugates and methods of making and using the same |
| 10/24/2002 | CA2763637A1 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 10/24/2002 | CA2490819A1 Compounds useful as anti-inflammatory agents |
| 10/24/2002 | CA2455274A1 Animal model for evaluating analgesics |
| 10/24/2002 | CA2447008A1 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 10/24/2002 | CA2445029A1 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase |
| 10/24/2002 | CA2444932A1 Aromatase inhibition to enhance assisted reproduction |
| 10/24/2002 | CA2444842A1 Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 10/24/2002 | CA2444840A1 Akt and regulation of ra synovial fibroblast apoptosis |
| 10/24/2002 | CA2444761A1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 10/24/2002 | CA2444596A1 Large conductance calcium-activated k channel opener |
| 10/24/2002 | CA2444548A1 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 10/24/2002 | CA2444481A1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 10/24/2002 | CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 10/24/2002 | CA2444455A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists |
| 10/24/2002 | CA2444421A1 Modification of the sustained release profile |
| 10/24/2002 | CA2444268A1 Gastric acid secretion inhibiting composition comprising an acid susceptible proton pump inhibitor and an h2 receptor antagonist |
| 10/24/2002 | CA2444267A1 Prodrugs of cox-2 inhibitors |
| 10/24/2002 | CA2444264A1 Prodrugs via acylation with cinnamate |
| 10/24/2002 | CA2444253A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae |
| 10/24/2002 | CA2444247A1 Inhibitors of integrin .alpha.v.beta.6 |